How to Reduce Pain in Patients Undergoing Office Hysteroscopy.

• Status: Not yet recruiting
• Trial end date: 2023-12-13
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to compare the effectiveness and the side effects of hyosine-N- butylbromide (HBB) & Celecoxib administered alone versus in combination reducing pain associated with outpatient hysteroscopy in married female patients aged 18-40 attending the outpatient hysteroscopy clinic of Kasr Al Ainy, Cairo University Hospital.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Bromides; Butylscopolammonium Bromide; Celecoxib; Scopolamine

Criteria

Inclusion Criteria:

• Patients indicated for diagnostic hysteroscopy including infertility, bleeding, suspected intrauterine pathologies (eg polypi, septae)

• Reproductive age 20 - 40yrs.

• Postmenstrual days from D-6 to D-11 of the cycle (except in irregular bleeding)

Exclusion Criteria:

• Menopausal and amenorrheic patients

• Contraindication to office hysteroscopy such as:- pelvic inflammatory disease, marked cervical stenosis, pregnancy

• Previous cervical surgery eg; cauterization and conization

• Patients whose vaginoscopic approach will not be enough and where a tenaculum will be used.

• Patients with peptic ulcers or other contraindications to HBB or celecoxib.

• Patients who will have an office operative procedure will be excluded.

• Patients who will refuse or ask to be excluded from the study after enrollment.